Table 5. View Large | American Society of Hematology

Table 5.

Novel drugs other than JAK1/JAK2 inhibitors with preclinical evidence of activity or already in clinical trials in patients with MF

Novel drugs other than JAK1/JAK2 inhibitors with preclinical evidence of activity or already in clinical trials in patients with MF

This Feature Is Available To Subscribers Only

Sign In or Create an Account